EXTRAVASCULAR HAEMOLYSIS

This adverse event was reported 425 times

These drugs are most commonly taken by patients reporting EXTRAVASCULAR HAEMOLYSIS:

# Drug Count
0 ECULIZUMAB 218
1 FOLIC ACID 33
2 DANICOPAN 20
3 DEFERASIROX 16
4 PEGCETACOPLAN 13
5 CYCLOSPORINE 12
6 PREDNISONE 12
7 OXALIPLATIN 10
8 ASPIRIN 9
9 ACETAMINOPHEN 8
See all common drugs associated with EXTRAVASCULAR HAEMOLYSIS

EXTRAVASCULAR HAEMOLYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DANICOPAN 20 0.0645
1 CROVALIMAB 6 0.0496
2 PEGCETACOPLAN 13 0.0068
3 IPTACOPAN 5 0.0063
4 ECULIZUMAB 218 0.0040
5 DEFEROXAMINE MESYLATE 2 0.0009
6 DEFERASIROX 16 0.0006
7 PENICILLIN V POTASSIUM 1 0.0004
8 DANAZOL 1 0.0004
9 FEBUXOSTAT TABLETS 40 MG 3 0.0003
See all drugs enriched for association with EXTRAVASCULAR HAEMOLYSIS

EXTRAVASCULAR HAEMOLYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Complement Factor D Inhibitor [EPC] 20 0.0645
1 Complement C5 Inhibitor [EPC] 6 0.0496
2 Complement Inhibitor [EPC] 228 0.0041
3 Iron Chelator [EPC] 16 0.0005
4 Vitamin D [EPC] 34 0.0001
5 Androgen [EPC] 3 0.0001
6 Vitamin B12 [EPC] 34 0.0001
7 Erythropoiesis-stimulating Agent [EPC] 5 0.0001
8 Calcineurin Inhibitor Immunosuppressant [EPC] 12 0.0001
9 Bile Acid [EPC] 2 0.0001
See all drug classes enriched for association with EXTRAVASCULAR HAEMOLYSIS